How much does a business broker charge to sell a business in South San Francisco?

Most business brokers charge a success fee — a commission paid only when the deal closes. For smaller businesses, the standard is often around 10% of the sale price, sometimes structured on a sliding scale as the price increases. Brokers handling South San Francisco's biotech-adjacent service businesses or larger life sciences transactions may also charge an upfront retainer or engagement fee, given the additional due diligence complexity these deals typically require.

How long does it take to sell a business in South San Francisco?

Most small-to-mid-size business sales take six to twelve months from listing to close. South San Francisco deals tied to the life sciences sector — such as contract research organizations, lab suppliers, or specialty staffing firms — can take longer due to the technical due diligence pharma and biotech acquirers require. Deals involving real estate, regulatory approvals, or complex IP arrangements add further time. Having financials audit-ready before listing shortens the process.

What is my South San Francisco business worth?

Valuation depends on your industry, profitability, growth trend, and asset base. Most small businesses sell for a multiple of Seller's Discretionary Earnings (SDE) or EBITDA. Businesses that directly serve South San Francisco's biotech cluster — lab staffing agencies, specialty logistics firms, or CROs — may command premium multiples because strategic life sciences acquirers compete aggressively for assets with proven biotech client relationships. A qualified broker or M&A advisor can run a formal valuation for your specific business.

Do I need a licensed broker to sell my business in California?

Yes, if the sale involves business assets and you are acting as an agent for someone else, California requires a Department of Real Estate (DRE) license to broker business-opportunity transactions. Selling your own business without a broker does not require a license, but most sellers use a licensed intermediary to protect themselves legally and reach qualified buyers. Always confirm that any broker you hire holds a current California DRE license before signing an engagement agreement.

How do I keep my business sale confidential in South San Francisco's biotech community?

Confidentiality is a real concern in South San Francisco, where the biotech and life sciences community is tightly networked. Standard practice is to market the business under a blind profile — no name, address, or identifying details — and require prospective buyers to sign a non-disclosure agreement before receiving any specifics. Your broker should pre-screen buyers for financial qualifications before disclosure. Telling employees, suppliers, or competitors prematurely can destabilize operations and reduce your sale price.

Who typically buys businesses in South San Francisco?

South San Francisco's buyer landscape is heavily shaped by its status as the Birthplace of Biotechnology, home to more than 250 biotech and pharma companies across roughly 11.5 million square feet of biopharma space. Strategic acquirers — including large pharma firms and venture-backed life sciences companies — are the dominant buyer type for sector-adjacent businesses. Individual owner-operators and private equity groups also purchase non-biotech businesses such as restaurants, retail shops, and professional service firms serving the local workforce.

What are the California DRE and CDTFA bulk-sale rules I need to know as a seller?

California imposes two key compliance layers on business sales. First, the DRE requires any agent brokering a business-opportunity sale to hold a real estate license. Second, the California Department of Tax and Fee Administration (CDTFA) administers bulk-sale notice requirements: when you sell business assets, the buyer must publish a public notice and open a tax escrow to protect against inheriting your unpaid sales-tax liabilities. Skipping the bulk-sale process can leave a buyer personally liable for your prior tax obligations.

What types of businesses sell the fastest in South San Francisco?

Businesses with clean financials, recurring revenue, and a location or client base tied to the area's dominant life sciences industry tend to attract buyers quickly. Specialty service firms — think clinical staffing, laboratory supply distribution, or facilities management with biotech contracts — draw interest from both strategic and financial buyers. Food-service and hospitality businesses near the biotech campuses also move relatively fast, given steady demand from a local workforce with a median household income above $135,000 as of 2023.

South San Francisco, California Business Brokers

BusinessBrokers.net is actively building its broker network in South San Francisco; no local brokers are listed yet. For now, search our California state directory or connect with a broker in a nearby covered city such as San Francisco, San Mateo, or Redwood City — many of whom regularly handle deals in San Mateo County's life sciences corridor.

0 Brokers in South San Francisco

BusinessBrokers.net is actively building its broker network in South San Francisco.

Market Overview

South San Francisco carries a designation no other city in the world can claim: the "Birthplace of Biotechnology." Genentech planted its roots here in 1976, and that founding moment set off a decades-long concentration of life sciences capital that now spans more than 250 biotech and pharma companies across roughly 11.5 million square feet of biopharma building space. That footprint shapes every corner of the local M&A market.

The city's population reached 64,487 in 2023, with a median household income of $135,909 — a figure that reflects the highly educated, well-compensated workforce clustered around the biotech campuses. California's Employment Development Department tracks South San Francisco as part of the San Francisco–Redwood City–South San Francisco Metropolitan Division, recognizing the city as an anchor in a multi-county life sciences labor and business corridor.

Nationally, small-business deal volume rose 5% in 2024, closing 9,546 transactions at a total enterprise value of $7.59 billion, according to BizBuySell's Year-End 2024 Insight Report. Median days on market dropped to 168 days — the fastest deal pace in recent years. California leads all U.S. states with 4.2 million small businesses, and service-sector listings here are sitting in a seller's market as buyer demand outpaces supply.

For South San Francisco, those national trends are amplified. When a pharma giant opens a campus on East Grand Avenue, dozens of support businesses — staffing firms, specialty caterers, logistics providers — grow up around it. Those businesses eventually come to market, and the buyers waiting for them are not typical Main Street acquirers.

Top Industries

Biotechnology & Life Sciences

Biotechnology and life sciences rank first by employment in South San Francisco, and the gap between this sector and everything below it is substantial. Genentech, now part of the Roche Group, anchors the cluster as both its founding institution and its largest employer. Pfizer, Merck, AstraZeneca, and Calico Life Sciences — an Alphabet subsidiary — have all established operations here, reinforcing the city's status as a global biotech address.

Recent deal activity confirms that the capital cycle is active. Arsenal Bio, headquartered in South San Francisco, closed a $325 million Series C financing round in September 2024 — one of the largest biotech fundraising events of that year. A separate South San Francisco-based biotech entered a strategic collaboration with Gilead Sciences in May 2024 to advance therapies for triple-negative breast cancer and non-small cell lung cancer. These are not incidental transactions; they signal a deal culture where large strategic buyers and venture-backed acquirers are continuously scanning the local landscape.

For business sellers, the relevance is direct: even if your company is not a drug developer, proximity to this cluster affects your valuation and your buyer pool.

Professional & Business Services

Professional and business services rank second by employment. Contract research organizations, regulatory consulting firms, specialized legal practices, and accounting firms built around life sciences clients fill the commercial corridors surrounding the biotech campuses. These businesses are frequent M&A targets because strategic acquirers — both corporate and private equity — want the client relationships and technical talent embedded in them. A CRO or compliance consultancy serving three major pharma clients on East Grand Avenue carries a buyer profile that looks nothing like a typical service-business sale.

Health Services, Hospitality & Logistics

Private education and health services rank third, followed by leisure and hospitality at fourth. Hotels, restaurants, and healthcare-adjacent support businesses serving the biotech workforce represent the most liquid segment for traditional small-business buyers. These deals move closer to national norms on valuation multiples and days on market.

Trade, transportation, and utilities round out the top five. South San Francisco's position on the San Francisco Bay and its border with San Bruno — home to San Francisco International Airport — creates a steady supply of logistics, courier, and airport-adjacent hospitality businesses with regional and national buyer interest.

Selling Your Business

Selling a business in South San Francisco starts with one compliance check that many first-time sellers overlook: confirming your broker holds an active California Department of Real Estate (DRE) broker license. Under Cal. Bus. & Prof. Code §10131(a), anyone who negotiates a business sale for compensation must hold that license. Operating without one is a criminal offense under §10139. Verify any broker's standing directly at dre.ca.gov before signing anything.

Once you have a licensed broker, the process moves through a predictable sequence: professional valuation, a confidential information memorandum (CIM), buyer qualification and NDA, letter of intent (LOI), due diligence, purchase agreement, and closing. Nationally, median days on market reached 168 days in 2024 (BizBuySell). SSF deals involving biotech-support firms — contract research organizations, lab-services companies, or IP-holding entities — routinely run longer due to regulatory, licensing, and intellectual property review layers that a standard Main Street transaction simply does not carry.

Two California-specific closing steps trip up sellers who skip them. First, the California Department of Tax and Fee Administration (CDTFA) bulk-sale tax clearance process: buyers acquiring any business with California sales tax obligations must file a bulk-sale notice to protect against inheriting the seller's unpaid tax liability. Miss this step and the buyer can be held responsible for the seller's back taxes. Second, the California Employment Development Department (EDD) requires payroll tax account transfers, and the California Secretary of State (SOS) must process any entity amendments tied to the sale. Start both early — they add weeks to a closing timeline if queued at the last minute.

Sellers in South San Francisco's biotech-adjacent service economy should also budget time for IP assignment review and any regulatory permits specific to life sciences support work, which can require parallel diligence tracks running alongside standard financial review.

Who's Buying

The buyer pool in South San Francisco splits sharply along industry lines, and understanding that divide shapes how you price and market a business.

Strategic and Institutional Buyers (Biotech-Adjacent Businesses)

For contract research organizations, lab-services firms, specialty staffing, and tech-enabled health services, the dominant acquirers are strategic buyers drawn from the 250-plus biotech and pharma companies operating across SSF's roughly 11.5 million square feet of biopharma space. Anchored by Roche/Genentech — which has called SSF home since its founding in 1976 — the cluster also includes Pfizer, Merck, AstraZeneca, and Calico Life Sciences (an Alphabet company). These organizations actively acquire capabilities that accelerate their pipelines rather than build them in-house. Venture-backed biotechs and PE-backed platform companies in the broader Bay Area corridor add a second layer of institutional demand. Arsenal Bio's $325 million Series C raise in September 2024 and a strategic collaboration between an SSF-based biotech and Gilead Sciences in May 2024 illustrate the pace of deal activity and the appetite institutional players bring to this market.

SBA-Backed and First-Time Buyers (Main Street Businesses)

Restaurants, retail shops, and personal-services businesses along the Grand Avenue and Downtown corridors attract a different profile entirely: individual owner-operators, many using SBA 7(a) financing, and first-generation buyers who bring hands-on operational plans rather than portfolio strategies.

Service-Sector Buyers Across Both Segments

Nationally, buyer demand for service-sector businesses outpaced available listings in 2024, putting sellers of healthcare-support, professional-services, and food-service businesses in a favorable negotiating position. Retirement drove 38% of seller decisions nationally in 2024 (BizBuySell), and SSF's established small-business owner base in non-biotech sectors mirrors that pattern — creating a steady pipeline of Main Street listings meeting motivated, qualified buyers.

Choosing a Broker

The first step is non-negotiable: confirm that any broker you consider holds an active California DRE real estate broker license. Under Cal. Bus. & Prof. Code §10131(a), the license is a legal requirement — not a preference. Run the verification yourself at dre.ca.gov before the first substantive conversation.

Biotech-Adjacent Businesses

For CROs, lab-services firms, IP-holding entities, or any business whose revenue depends on the SSF biotech cluster, the broker's deal history matters more than their logo. Ask specifically how many life sciences or technology-enabled health-services transactions they have closed, and ask for evidence — not just a reference list. A broker with direct relationships among strategic acquirers at the Roche/Genentech campus or in the broader Peninsula life sciences corridor brings materially different access than a generalist. Credentials like the M&AMI (Merger & Acquisition Master Intermediary) designation signal training in complex, higher-valuation deals, which is relevant in this market.

Main Street Businesses

For restaurants, retail, and services businesses, Peninsula and San Mateo County market knowledge is the key differentiator. A broker who tracks sale multiples along the Grand Avenue corridor and maintains an active local buyer database will price and place your listing more accurately than one working from national comps alone. The South San Francisco Chamber of Commerce (213 Linden Ave) is a practical starting point for referrals to brokers, attorneys, and accountants with verified SSF transaction experience.

Questions to Ask Any Broker

Ask every candidate to walk you through California's CDTFA bulk-sale clearance process, EDD payroll tax account transfer requirements, and SOS entity amendment steps. A broker who cannot explain all three has likely not closed many California deals — and South San Francisco transactions require all three.

Fees & Engagement

Business broker commissions in California small-business transactions typically follow a modified Lehman Formula — starting around 10% on the first $1 million of sale price and stepping down on value above that threshold. These are negotiable, and the actual percentage in any deal depends on business size, complexity, and what the market will bear. For high-valuation biotech-adjacent transactions common in SSF, buyers and sellers sometimes negotiate meaningfully lower percentage rates given the larger deal sizes involved.

Upfront retainer fees — commonly in the $2,000–$10,000-plus range in California — cover the broker's preparation work: valuation analysis, CIM drafting, and marketing. Ask explicitly whether that retainer credits against the success fee at closing or is charged separately. The answer varies by broker and should be spelled out in writing before you sign.

Because California requires business brokers to hold a DRE license, the engagement agreement you sign functions similarly to a California real estate listing agreement — it is a legal document, not an informal arrangement. Expect it to specify the listing term (typically six to twelve months), exclusivity provisions, commission structure, and what happens if you find a buyer independently.

For businesses with significant intellectual property — common in SSF's life sciences support sector — a separate valuation engagement with a certified business appraiser or M&A advisor may be necessary before a broker is even brought in. That work is a separate fee line and is money well spent given SSF's median household income of $135,909 and the premium valuations that biotech-adjacent real estate and business assets command in this market.

Buyers in standard small-business transactions pay no broker commission. The seller-paid success fee is the norm in SSF as across California.

Local Resources

[South San Francisco Chamber of Commerce](https://www.ssfchamber.com/) — 213 Linden Ave, South San Francisco, CA 94080. The hyperlocal starting point for referrals to brokers, attorneys, and accountants with direct SSF transaction experience. The Chamber's network connects you to professionals who know the Grand Avenue corridor and the biotech-adjacent business community firsthand.

[SCORE San Francisco & East Bay](https://www.score.org/sanfranciscoeastbay) — 455 Market St, Ste 600, San Francisco, CA 94105. Free one-on-one mentoring from experienced business advisors. Particularly useful for exit planning, preliminary valuation work, and understanding what buyers will scrutinize during due diligence.

[SBA San Francisco District Office](https://www.sba.gov/district/san-francisco) — 455 Market St, Ste 600, San Francisco, CA 94105 | (415) 744-6820. Administers SBA 7(a) loan programs that buyers commonly use to finance SSF Main Street acquisitions; also a resource for sellers preparing their financials to meet lender standards.

[San Mateo Daily Journal](https://www.smdailyjournal.com/) — The primary local news outlet covering SSF economic development, business community news, and biotech deal activity, including Genentech Day coverage and Peninsula M&A reporting.

[California Department of Real Estate (DRE)](https://www.dre.ca.gov/) — Verify any broker's license status here before engaging them. Required under Cal. Bus. & Prof. Code §10131(a).

[California Department of Tax and Fee Administration (CDTFA)](https://www.cdtfa.ca.gov/) — Manages bulk-sale tax clearance, a mandatory step in most SSF business transactions to protect buyers from successor tax liability.

Areas Served

East Grand Avenue / Utah–Connecticut Biotech Corridor

The stretch of East Grand Avenue and the Utah–Connecticut grid forms the commercial core of South San Francisco's biotech cluster. Businesses operating here — whether they provide facility services, specialized staffing, or scientific equipment — sit inside the highest-value submarket in the city. Strategic buyers from the pharma industry routinely pay premium multiples for footholds in this corridor.

Downtown / Grand Avenue

The Grand Avenue commercial strip serves the broader residential and workforce population. Retail, restaurants, and personal-service businesses here follow more traditional small-business sale dynamics, with a buyer pool that extends across the Peninsula.

Lindenville

The Lindenville district is actively being rezoned to accommodate life sciences and creative industry uses. Sellers in this area and buyers seeking life sciences-adjacent space at pre-appreciation prices should pay close attention to how quickly that zoning shift affects business valuations.

SFO-Adjacent / San Bruno Border

The city's southern edge borders San Bruno and sits minutes from San Francisco International Airport. Hospitality, logistics, and transportation businesses in this zone draw buyers from across the Bay Area.

Brokers serving South San Francisco typically cover a unified Peninsula market that includes San Mateo, San Francisco, Palo Alto, Oakland, San Jose, and Fremont.

Last reviewed by BBNet Editorial Team on May 1, 2026.

Frequently Asked Questions About South San Francisco Business Brokers

How much does a business broker charge to sell a business in South San Francisco?: Most business brokers charge a success fee — a commission paid only when the deal closes. For smaller businesses, the standard is often around 10% of the sale price, sometimes structured on a sliding scale as the price increases. Brokers handling South San Francisco's biotech-adjacent service businesses or larger life sciences transactions may also charge an upfront retainer or engagement fee, given the additional due diligence complexity these deals typically require.
How long does it take to sell a business in South San Francisco?: Most small-to-mid-size business sales take six to twelve months from listing to close. South San Francisco deals tied to the life sciences sector — such as contract research organizations, lab suppliers, or specialty staffing firms — can take longer due to the technical due diligence pharma and biotech acquirers require. Deals involving real estate, regulatory approvals, or complex IP arrangements add further time. Having financials audit-ready before listing shortens the process.
What is my South San Francisco business worth?: Valuation depends on your industry, profitability, growth trend, and asset base. Most small businesses sell for a multiple of Seller's Discretionary Earnings (SDE) or EBITDA. Businesses that directly serve South San Francisco's biotech cluster — lab staffing agencies, specialty logistics firms, or CROs — may command premium multiples because strategic life sciences acquirers compete aggressively for assets with proven biotech client relationships. A qualified broker or M&A advisor can run a formal valuation for your specific business.
Do I need a licensed broker to sell my business in California?: Yes, if the sale involves business assets and you are acting as an agent for someone else, California requires a Department of Real Estate (DRE) license to broker business-opportunity transactions. Selling your own business without a broker does not require a license, but most sellers use a licensed intermediary to protect themselves legally and reach qualified buyers. Always confirm that any broker you hire holds a current California DRE license before signing an engagement agreement.
How do I keep my business sale confidential in South San Francisco's biotech community?: Confidentiality is a real concern in South San Francisco, where the biotech and life sciences community is tightly networked. Standard practice is to market the business under a blind profile — no name, address, or identifying details — and require prospective buyers to sign a non-disclosure agreement before receiving any specifics. Your broker should pre-screen buyers for financial qualifications before disclosure. Telling employees, suppliers, or competitors prematurely can destabilize operations and reduce your sale price.
Who typically buys businesses in South San Francisco?: South San Francisco's buyer landscape is heavily shaped by its status as the Birthplace of Biotechnology, home to more than 250 biotech and pharma companies across roughly 11.5 million square feet of biopharma space. Strategic acquirers — including large pharma firms and venture-backed life sciences companies — are the dominant buyer type for sector-adjacent businesses. Individual owner-operators and private equity groups also purchase non-biotech businesses such as restaurants, retail shops, and professional service firms serving the local workforce.
What are the California DRE and CDTFA bulk-sale rules I need to know as a seller?: California imposes two key compliance layers on business sales. First, the DRE requires any agent brokering a business-opportunity sale to hold a real estate license. Second, the California Department of Tax and Fee Administration (CDTFA) administers bulk-sale notice requirements: when you sell business assets, the buyer must publish a public notice and open a tax escrow to protect against inheriting your unpaid sales-tax liabilities. Skipping the bulk-sale process can leave a buyer personally liable for your prior tax obligations.
What types of businesses sell the fastest in South San Francisco?: Businesses with clean financials, recurring revenue, and a location or client base tied to the area's dominant life sciences industry tend to attract buyers quickly. Specialty service firms — think clinical staffing, laboratory supply distribution, or facilities management with biotech contracts — draw interest from both strategic and financial buyers. Food-service and hospitality businesses near the biotech campuses also move relatively fast, given steady demand from a local workforce with a median household income above $135,000 as of 2023.